To overcome this, following promising data in mice,92, 117 an engineered IL‐2 diptheria toxin construct was used to deplete Treg in AML patients prior to NK cell infusion; this resulted in increased donor NK cell expansion post‐transplant and significant improvements in remission and survival rates.51 Here, IL2 is linked to acute myeloid leukemia.